Every 8-K that Virnetx Holding (VHC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow VHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VHC filings page.
VirnetX Holding Corporation reported the results of its 2026 annual meeting of stockholders. Stockholders approved an amendment to the Amended and Restated 2013 Equity Incentive Plan, increasing the number of shares of common stock reserved for issuance under the plan by 1,000,000 shares.
Two Class I directors, Kendall Larsen and Gary W. Feiner, were elected to serve until the 2029 annual meeting. Stockholders ratified the appointment of Farber Hass Hurley LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved, on an advisory basis, the compensation of the company’s named executive officers. A quorum was present, with 2,639,678 shares represented, equal to 63.06% of the voting power as of the April 16, 2026 record date.
VirnetX Holding Corporation furnished an Item 7.01 update announcing it was awarded a GSA Schedule contract, as stated in a press release titled “VirnetX Awarded Coveted GSA Schedule Contract - Contract Expands Federal Access to Secure Communications and Zero-Trust Cybersecurity Solutions.” The information, including Exhibit 99.1, was furnished and is not deemed “filed” under Section 18. The exhibits include the press release and the Inline XBRL cover page file.
VirnetX Holding Corporation is moving the listing of its common stock from the New York Stock Exchange to The Nasdaq Stock Market LLC. The company notified the NYSE on September 11, 2025 that it intends to voluntarily withdraw its listing and transfer to Nasdaq.
VirnetX expects trading of its common stock on the NYSE to end at market close on or about September 22, 2025, with trading on Nasdaq beginning at market open on or about September 23, 2025. The stock has been approved for listing on Nasdaq and will continue to trade under the ticker symbol “VHC”. The company also issued a press release describing the planned transfer.